Defence Therapeutics Inc.
DTC
Kedudukan dalam Saham
#29270
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Harga Saham
$0.27889602
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$21.14M
Perubahan (1 hari)
11.76%
Perubahan (1 tahun)
-52.35%
Negara
CA
Perdagangan Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Sejarah pecahan saham untuk Defence Therapeutics Inc. (DTC)
Saham Defence Therapeutics Inc. (simbol: DTC) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham DTC yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham DTC.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham DTC yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham DTC.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
